MedPath

The comparison of the effectiveness of two injectable medications for the treatment of hand osteoarthritis

Phase 2
Conditions
Osteoarthritis.
Arthrosis
M15, M16,
Registration Number
IRCT201011025088N1
Lead Sponsor
Research group of 501 army university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion:1-Age>40 2-First carpometacarpal joint pain over 3/10 on VAS scale with symptoms present greater than 3 months 3-Confirmation of CMC osteoarthritis with radiography 4-The Gripping disorder in functional assessment scores 5-Ability to make follow up visits over the 6-month protocol. Exclusion:1-Recent trauma to the hand or fractures seen on radiographs 2-History of joint inflammatory or infectious disorder 3-Allergies to injected solutions 4-CMC joint injections in the prior 6 months.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before injection and 1, 2 and 6 months after the last injection. Method of measurement: VAS scale.
Secondary Outcome Measures
NameTimeMethod
Hand function and pinch grip strength. Timepoint: Before injection and 1, 2 and 6 months after the last injection. Method of measurement: HAQ-I scale and Pinch guage.
© Copyright 2025. All Rights Reserved by MedPath